IN2014DN00254A - - Google Patents

Download PDF

Info

Publication number: IN2014DN00254A
Authority: IN; India
Prior art keywords: compositions; treatment; invention include; include methods; adipose deposits
Prior art date: 2011-07-20

Application number

Other languages

English (en)

Inventor

Katherine Cernok

Kenneth Martinez

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-07-20

Filing date

2012-07-19

Publication date

2015-06-05

2012-07-19 Application filed by Allergan Inc filed Critical Allergan Inc

2015-06-05 Publication of IN2014DN00254A publication Critical patent/IN2014DN00254A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
- A61K38/4893—Botulinum neurotoxin (3.4.24.69)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Birds (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Dermatology (AREA)
Child & Adolescent Psychology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

IN254DEN2014 2011-07-20 2012-07-19 IN2014DN00254A (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161509700P	2011-07-20	2011-07-20
PCT/US2012/047405 WO2013013042A1 (en)	2011-07-20	2012-07-19	Botulinum toxins for use in a method for treatment of adipose deposits

Publications (1)

Publication Number	Publication Date
IN2014DN00254A true IN2014DN00254A (de)	2015-06-05

Family

ID=46601917

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN254DEN2014 IN2014DN00254A (de)	2011-07-20	2012-07-19

Country Status (12)

Country	Link
US (1)	US20140127188A1 (de)
EP (1)	EP2734224A1 (de)
JP (1)	JP2014520892A (de)
KR (1)	KR20140082956A (de)
CN (1)	CN103702681A (de)
AU (1)	AU2012283968B2 (de)
BR (1)	BR112014001066A2 (de)
CA (1)	CA2841955A1 (de)
IN (1)	IN2014DN00254A (de)
MX (1)	MX2014000612A (de)
RU (1)	RU2014103543A (de)
WO (1)	WO2013013042A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9486408B2 (en)	2005-12-01	2016-11-08	University Of Massachusetts Lowell	Botulinum nanoemulsions
US9655926B1 (en)	2013-08-23	2017-05-23	Amiya Prasad	Treatment for hair thinning and hair loss
US9884001B2 (en) *	2014-08-07	2018-02-06	Sang Duck Kim	Botulinum toxin in aerosol form and method of facial contouring using the same
CN108602840B (zh)	2015-12-18	2021-05-28	南大光电半导体材料有限公司	高纯度三甲硅烷基胺、制备方法和用途
JP2019535829A (ja)	2016-11-21	2019-12-12	エイリオンセラピューティクス，インコーポレイテッド	大型薬剤の経皮送達
JP2020520917A (ja) *	2017-05-18	2020-07-16	ルバンスセラピュティックスインク．ＲｅｖａｎｃｅＴｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ．	頸部ジストニアの治療方法
US20190030118A1 (en) *	2017-07-27	2019-01-31	Ipsen Biopharm Limited	Treatment of lower limb spasticity

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9120306D0 (en)	1991-09-24	1991-11-06	Graham Herbert K	Method and compositions for the treatment of cerebral palsy
US5437291A (en)	1993-08-26	1995-08-01	Univ Johns Hopkins	Method for treating gastrointestinal muscle disorders and other smooth muscle dysfunction
US6974578B1 (en)	1993-12-28	2005-12-13	Allergan, Inc.	Method for treating secretions and glands using botulinum toxin
US5766605A (en)	1994-04-15	1998-06-16	Mount Sinai School Of Medicine Of The City University Of New York	Treatment of autonomic nerve dysfunction with botulinum toxin
US5670484A (en)	1994-05-09	1997-09-23	Binder; William J.	Method for treatment of skin lesions associated with cutaneous cell-proliferative disorders
WO1995030431A1 (en)	1994-05-09	1995-11-16	Binder William J	Method for reduction of headache pain
GB9508204D0 (en)	1995-04-21	1995-06-07	Speywood Lab Ltd	A novel agent able to modify peripheral afferent function
DE69833059T3 (de)	1997-07-15	2014-12-18	The Regents Of The University Of Colorado, A Body Corporate	Verwendung von Botulinumtoxin zur Behandlung von Harninkontinenz
US6063768A (en)	1997-09-04	2000-05-16	First; Eric R.	Application of botulinum toxin to the management of neurogenic inflammatory disorders
US6113915A (en)	1999-10-12	2000-09-05	Allergan Sales, Inc.	Methods for treating pain
US6265379B1 (en)	1999-10-13	2001-07-24	Allergan Sales, Inc.	Method for treating otic disorders
US6139845A (en)	1999-12-07	2000-10-31	Allergan Sales, Inc.	Method for treating cancer with a neurotoxin
US6143306A (en)	2000-01-11	2000-11-07	Allergan Sales, Inc.	Methods for treating pancreatic disorders
US6358513B1 (en)	2000-02-15	2002-03-19	Allergan Sales, Inc.	Method for treating Hashimoto's thyroiditis
US6328977B1 (en)	2000-02-22	2001-12-11	Allergan Sales, Inc.	Method for treating hyperparathyroidism
US6464986B1 (en)	2000-04-14	2002-10-15	Allegan Sales, Inc.	Method for treating pain by peripheral administration of a neurotoxin
US6299893B1 (en)	2000-04-17	2001-10-09	Marvin Schwartz	Method to reduce hair loss and stimulate hair regrowth
US6306423B1 (en)	2000-06-02	2001-10-23	Allergan Sales, Inc.	Neurotoxin implant
US6306403B1 (en)	2000-06-14	2001-10-23	Allergan Sales, Inc.	Method for treating parkinson's disease with a botulinum toxin
US6423319B1 (en)	2000-10-04	2002-07-23	Allergan Sales, Inc.	Methods for treating muscle injuries
WO2004016763A2 (en) *	2002-08-19	2004-02-26	Ira Sanders	Treatment of holocrine gland dysfunction with clostridia neurotoxins
EP2985039B1 (de) *	2004-03-03	2018-08-01	ReVance Therapeutics, Inc.	Topische anwendung und transdermale abgabe von botulinumtoxinen
US7179474B2 (en) *	2004-09-03	2007-02-20	Allergan, Inc.	Methods for treating a buttock deformity
CA2518650A1 (en) *	2004-09-10	2006-03-10	Dimitrios Dimitrakoudis	Clostridium botulinum toxin formulation and method for reducing weight
US7727537B2 (en) *	2005-02-14	2010-06-01	Dpm Therapeutics Corp.	Stabilized compositions for topical administration and methods of making same
US20080220021A1 (en) *	2005-02-14	2008-09-11	Pankaj Modi	Topical Botulinum Toxin Compositions for the Treatment of Hyperhidrosis
MX2008006750A (es) *	2005-12-01	2008-09-03	Univ Massachusetts Lowell	Nanoemulsiones de botulinum.
KR101503958B1 (ko) *	2007-08-31	2015-03-18	디에스엠 아이피 어셋츠 비.브이.	미용 및/또는 피부과학적 용도의 4-아미디노 벤질아민
US20090297632A1 (en) *	2008-06-02	2009-12-03	Waugh Jacob M	Device, Methods and Compositions to Alter Light Interplay with Skin
KR102080429B1 (ko) *	2008-06-26	2020-02-21	안테리오스, 인코퍼레이티드	경피 운반
JP6006940B2 (ja) *	2009-03-02	2016-10-12	ヘクセル，ドリス	医学的美容脂肪萎縮方法

2012
- 2012-07-19 CN CN201280035860.8A patent/CN103702681A/zh active Pending
- 2012-07-19 BR BR112014001066A patent/BR112014001066A2/pt not_active Application Discontinuation
- 2012-07-19 IN IN254DEN2014 patent/IN2014DN00254A/en unknown
- 2012-07-19 JP JP2014521786A patent/JP2014520892A/ja active Pending
- 2012-07-19 CA CA2841955A patent/CA2841955A1/en not_active Abandoned
- 2012-07-19 RU RU2014103543/15A patent/RU2014103543A/ru not_active Application Discontinuation
- 2012-07-19 WO PCT/US2012/047405 patent/WO2013013042A1/en active Application Filing
- 2012-07-19 MX MX2014000612A patent/MX2014000612A/es unknown
- 2012-07-19 KR KR1020147004213A patent/KR20140082956A/ko not_active Withdrawn
- 2012-07-19 US US14/233,667 patent/US20140127188A1/en not_active Abandoned
- 2012-07-19 EP EP12741438.1A patent/EP2734224A1/de not_active Withdrawn
- 2012-07-19 AU AU2012283968A patent/AU2012283968B2/en not_active Ceased

Also Published As

Publication number	Publication date
US20140127188A1 (en)	2014-05-08
CA2841955A1 (en)	2013-01-24
RU2014103543A (ru)	2015-08-27
WO2013013042A1 (en)	2013-01-24
KR20140082956A (ko)	2014-07-03
CN103702681A (zh)	2014-04-02
AU2012283968A1 (en)	2014-02-06
EP2734224A1 (de)	2014-05-28
MX2014000612A (es)	2014-02-27
AU2012283968B2 (en)	2016-04-14
BR112014001066A2 (pt)	2017-02-21
JP2014520892A (ja)	2014-08-25

Publication	Publication Date	Title
IN2015DN00127A (de)	2015-05-29
MX2013011479A (es)	2013-11-04	Anticuerpos anti-fgfr4 y metodos de uso.
MX2013015311A (es)	2014-03-31	Polipeptidos de enlace de pcsk9 y metodos de uso.
GB201103062D0 (en)	2011-04-06	Method
MX2014002053A (es)	2014-04-25	Anticuerpos anti -mcsp y metodos de uso.
PH12014500841B1 (en)	2019-11-29	ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
PH12015500525A1 (en)	2015-05-04	Formulations of enzalutamide
IN2014CN04765A (de)	2015-09-18
MX355728B (es)	2018-04-27	Inhibidores de cinasas.
PH12013501339A1 (en)	2013-08-28	Anti-pcsk9 antibodies and methods of use
MX355543B (es)	2018-04-20	Macrociclos peptidomiméticos.
PH12014501605A1 (en)	2014-10-08	Anti-lrp5 antibodies and methods of use
MX340555B (es)	2016-07-14	Anticuerpos contra il-18r1 y usos de los mismos.
IN2014CN03555A (de)	2015-07-03
MY157341A (en)	2016-05-31	Methods and compositions for treating lung cancer
PH12014501032A1 (en)	2014-10-20	2-thiopyrimidinones
IN2014CN04634A (de)	2015-09-18
MX336323B (es)	2016-01-15	Anticuerpos de anti-poliubiquitina y metodos de uso.
IN2014DN00254A (de)	2015-06-05
IN2014DN09450A (de)	2015-07-17
IN2013MU00848A (de)	2015-05-01
MX393754B (es)	2025-03-24	Metodos y composiciones para inhibir cnksr1
MX359181B (es)	2018-09-17	Hidrolizado de colágeno y uso del mismo.
MX363385B (es)	2019-03-20	Métodos para el tratamiento de enfermedad de células falciformes y otras condiciones inflamatorias.
MX347541B (es)	2017-04-28	Analogos de acido sialico.